ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

September 13, 2002

Chabner Cautions Against Downsizing, Consolidation Of NCI Intramural Programs

March 3, 1995

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998